Breast oncology Clinical Trials in Atlanta, GA
As of August 2026, 39 paid clinical trials are recruiting for Breast oncology in Atlanta, Georgia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Atlanta
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
40 clinical trials for Breast oncology
·Clear filters·A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
A Beta-only IL-2 ImmunoTherapY Study
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
E-Mindfulness Approaches for Living After Breast Cancer
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Top Research Study Locations in Atlanta
Researchers run research studies in Atlanta, GA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Emory University | Coronary Artery Disease, Parkinson Disease, Prostate Cancer | 216 |
| Emory University Hospital/Winship Cancer Institute | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 120 |
| Emory University Hospital Midtown | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 116 |
| Emory University Hospital | Multiple Myeloma, Coronary Artery Disease, Stroke | 97 |
| Emory Saint Joseph's Hospital | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 | 79 |
| Children's Healthcare of Atlanta | Sickle Cell Disease, Neuroblastoma, Acute Leukemia of Ambiguous Lineage | 60 |
| Grady Health System | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 47 |
| Northside Hospital | Non-Hodgkin Lymphoma, Stage IV Lung Cancer AJCC v8, Acute Lymphoblastic Leukemia | 47 |
| Emory University School of Medicine | Colorectal Cancer, Diabetes, Fabry Disease | 44 |
| Children's Healthcare of Atlanta - Arthur M Blank Hospital | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 33 |
| Grady Memorial Hospital | Human Immunodeficiency Virus, Intracerebral Hemorrhage, Colorectal Neoplasms | 31 |
| Winship Cancer Institute, Emory University | Advanced Solid Tumor, Breast Cancer, Endometrial Cancer | 30 |
| Winship Cancer Institute of Emory University | Multiple Myeloma, Breast Cancer, Diffuse Large B Cell Lymphoma | 27 |
| Emory Winship Cancer Institute | Ovarian Cancer, Acute Myeloid Leukemia, Breast Cancer Metastatic | 23 |
| Piedmont Heart Institute | Aortic Valve Stenosis, Atrial Fibrillation (AF), Cardiovascular Diseases | 23 |
| Piedmont Healthcare | Pancreatic Ductal Adenocarcinoma (PDAC), Non-Small Cell Lung Cancer, PDAC | 22 |
| Winship Cancer Institute | Breast Cancer, Breast Neoplasms, NSCLC (Non-small Cell Lung Cancer) | 16 |
| Emory Proton Therapy Center | Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8, Advanced Hepatocellular Carcinoma | 15 |
| Atlanta Center for Medical Research | Schizophrenia, Bipolar Disorder, Generalized Anxiety Disorder | 13 |
| Piedmont Hospital | Intracranial Meningioma, Anatomic Stage IV Breast Cancer AJCC v8, Atrial Fibrillation, Postoperative | 13 |
| Georgia State University | Adult, Cognition, Endothelial Function (Reactive Hyperemia) | 12 |
| Emory University Winship Cancer Institute | Advanced Solid Tumors, Autoimmune Diseases, Breast Cancer | 11 |
| Morehouse School of Medicine | Crohn Disease, Bowel Cleansing for Colonoscopy, Cancer | 11 |
| The Emory Clinic | Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Cervical Cancer | 11 |
| Emory Clinic | Advanced Glenohumeral Osteoarthritis, Aortic Aneurysm, Abdominal, Chronic Kidney Disease | 10 |
Active & Upcoming Studies in Atlanta (2026)
Recruiting trials in Atlanta grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (452 active studies)
- Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma · Phase 2 · National Cancer Institute (NCI)
- Axatilimab + CAR-T for High-Risk Lymphoma · Phase 1 · Northside Hospital, Inc.
Cardiovascular (103 active studies)
- CGM Use in Heart Failure · Emory University
- NHLBI-Emory Advanced Cardiac CT Reconstruction · National Heart, Lung, and Blood Institute (NHLBI)
Neurology & pain (80 active studies)
- Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke · Georgia Institute of Technology
- Electrophysiologic Mechanisms of Ketamine Antidepressant Response · Phase 2 · Emory University
Mental health & behavior (65 active studies)
- A Mindfulness-based Intervention for Sexual Assault Survivors · Georgia State University
- Quantifying Multi-step Avoidance in Anxiety · Emory University
Diabetes & metabolic (46 active studies)
- CGM Use in Heart Failure · Emory University
- Diabetes Multimorbidity Typology, Trajectory, and Feasibility of an Audio Diary Mobile Application to Support Self-management · Emory University
HIV / STI (36 active studies)
- Project SPACE: Testing Daily Text Messages to Reduce Alcohol Use and HIV Risk Behavior · Emory University
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Pediatric (24 active studies)
Vaccines (15 active studies)
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age · Phase 3 · GlaxoSmithKline
- Improving Vaccine Acceptance Through EHR Integrated Patient- and Provider-Facing Decision Support · Johns Hopkins Bloomberg School of Public Health
Eye & vision (4 active studies)
- Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants · Phase 4 · Neurotech Pharmaceuticals
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study · Iantrek, Inc.
Common conditions studied in Atlanta
- Multiple Myeloma (28 active studies)
- Breast Cancer (21 active studies)
- Sickle Cell Disease (19 active studies)
- Schizophrenia (18 active studies)
- Acute Myeloid Leukemia (16 active studies)
- Heart Failure (15 active studies)
Leading research sponsors in Atlanta
- Emory University
- National Cancer Institute (NCI)
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Atlanta?
There are approximately 1,472 recruiting clinical trials in Atlanta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Atlanta pay participants?
Most recruiting trials in Atlanta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Atlanta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Atlanta?
The most common conditions under active study in Atlanta include Multiple Myeloma (28), Breast Cancer (21), Sickle Cell Disease (19), Schizophrenia (18), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Atlanta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Atlanta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Atlanta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Atlanta?
Recruiting research sites in Atlanta include Emory University, Emory University Hospital/Winship Cancer Institute, Emory University Hospital Midtown, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Atlanta right now?
The largest active categories in Atlanta are Cancer & tumors (452), Cardiovascular (103), Neurology & pain (80). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.